HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of facial postinflammatory hyperpigmentation with facial acne in Asian patients using a Q-switched neodymium-doped yttrium aluminum garnet laser.

AbstractBACKGROUND:
Postinflammatory hyperpigmentation (PIH) due to facial acne commonly occurs in Fitzpatrick skin types IV to VI and can have a considerable effect on quality of life. The sequelae in terms of pigmentation are often the main reason for consulting a dermatologist and take precedence over the acne itself.
OBJECTIVE:
The purpose of this study was to evaluate a new combined photoacoustic-photothermal low-fluence Q-switched neodymium-doped yttrium aluminum garnet (QSNY) laser in the treatment for facial acne and PIH.
METHODS:
Twenty individuals underwent five weekly full-facial treatments using a QSNY laser at 1,064 nm. Another 20 individuals underwent five weekly facial acne treatments by extraction of comedones, and intralesional injections into severely inflamed papules were performed at each treatment session. Clinical assessment scores were determined 1 and 3 months after the last treatment.
RESULTS:
QSNY laser treatments at 1,064 nm were found to be effective at treating PIH and have an additional effect on concomitant acne lesions. The authors have indicated no significant interest with commercial supporters.
AuthorsSangeun Kim, Kyeong-Hun Cho
JournalDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (Dermatol Surg) Vol. 36 Issue 9 Pg. 1374-80 (Sep 2010) ISSN: 1524-4725 [Electronic] United States
PMID20629693 (Publication Type: Journal Article)
Copyright© 2010 by the American Society for Dermatologic Surgery, Inc.
Topics
  • Acne Vulgaris (complications, surgery)
  • Adult
  • Dermatitis (etiology)
  • Face
  • Humans
  • Hyperpigmentation (etiology, surgery)
  • Lasers, Solid-State (therapeutic use)
  • Republic of Korea
  • Skin Diseases (etiology, surgery)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: